Serum 25-OH Vitamin D Level in Psoriatic Patients and Comparison With Control Subjects

被引:28
|
作者
Maleki, Masoud [1 ]
Nahidi, Yalda [1 ]
Azizahari, Sahar [1 ]
Meibodi, Naser Tayyebi [2 ]
Hadianfar, Ali [3 ]
机构
[1] Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Dept Dermatol, Sch Med, Mashhad, Iran
[2] Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Dept Pathol, Mashhad, Iran
[3] Mashhad Univ Med Sci, Dept Biostat & Epidemiol, Mashhad, Iran
关键词
psoriasis; serum vitamin D; Psoriasis Area and Severity Index (PASI); ULTRAVIOLET-B TREATMENT; 25-HYDROXYVITAMIN D; D DEFICIENCY; PHOTOTHERAPY; RECEPTOR; THERAPY; CANCER;
D O I
10.1177/1203475415622207
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Vitamin D has been shown to have immunomodulatory effects, and previous studies have proposed a role of vitamin D deficiency in multiple autoimmune diseases, including psoriasis. Objectives: The aim of this study was to investigate serum vitamin D levels in psoriatic patients and compare them with levels in controls. Methods: This study was carried out in 50 psoriasis patients. Serum vitamin D was measured by enzyme-linked immunosorbent assay. Results: The mean serum vitamin D levels in psoriatic patients and controls were 14.92 6.31 and 12.52 +/- 4.54 ng/mL, respectively. The difference was not statistically significant (P = .06). The prevalence of vitamin D deficiency (<20 ng/mL) was 84.0% in psoriatic patients and 93.0% in controls (P = .21). Conclusions: Most of the patients with psoriasis had vitamin D deficiency, which may have contributed to the evolution of their psoriasis. However, considering the high prevalence of vitamin D deficiency in Iran, no difference was noted between the psoriatic patients and the controls.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [1] Serum 25-OH vitamin D level in patients with schizophrenia spectrum disorders
    Kopecek, M.
    Knytl, D. Protopopova P.
    Kohutova, B.
    Hanka, J.
    Mohr, P.
    EUROPEAN PSYCHIATRY, 2017, 41 : S817 - S817
  • [2] Serum 25-OH Vitamin D Levels in Patients with Fibromyalgia
    Tandeter, Howard
    Grynbaum, Mirta
    Zuili, Irene
    Shany, Shraga
    Shvartzman, Pesach
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (06): : 339 - 342
  • [3] ABSORPTION OF VITAMIN-D AND 25-OH VITAMIN-D (25-OH D) IN PATIENTS WITH STEATORRHEA
    KRAWITT, EL
    CHASTENAY, B
    GASTROENTEROLOGY, 1979, 76 (05) : 1177 - 1177
  • [4] Serum 25-OH vitamin D3 in chronic rheumatic patients
    Delle, SA
    Mazzantini, M
    Frigelli, S
    Di Munno, O
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S136 - S136
  • [5] SERUM 25-OH VITAMIN-D AFTER PHOTOCHEMOTHERAPY
    SHUSTER, S
    CHADWICK, L
    MOSS, C
    MARKS, J
    BRITISH JOURNAL OF DERMATOLOGY, 1981, 105 (04) : 421 - 423
  • [6] SERUM 25-OH VITAMIN-D AFTER PHOTOCHEMOTHERAPY
    SHUSTER, S
    CHADWICK, L
    MOSS, C
    MARKS, JM
    BRITISH JOURNAL OF DERMATOLOGY, 1981, 105 (03) : 339 - 339
  • [7] Serum 25-OH Vitamin D and Parathyroid Hormone Levels in Beta Thalassemia Patients
    Turkkan, Emine
    Tas, Burcu Tufan
    Ocak, Suheyla
    BLOOD, 2015, 126 (23)
  • [8] Risk of hypercalcemia in patients with very high serum 25-OH vitamin D levels
    Batman, Adnan
    Saygili, Emre Sedar
    Yildiz, Duygu
    Sen, Esra Cil
    Erol, Rumeysa Selvinaz
    Canat, Muhammed Masum
    Ozturk, Feyza Yener
    Altuntas, Yuksel
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [9] Plasma 25-OH Vitamin D3 Level in HIV Infected Patients
    Deveci, Aydin
    Bilgici, Birsen
    PROGRESS IN NUTRITION, 2021, 23 (02):
  • [10] Serum 25-OH vitamin D3 in chronic rheumatic patients.
    Di Munno, O
    Delle Sedie, A
    Mazzantini, M
    Frigelli, S
    Metelli, MR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S312 - S312